MAM
STIM icon

Meeder Asset Management’s Neuronetics STIM Stock Holding History

Meeder Asset Management’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,379
Closed -$3K – 2444
2020
Q1 		$3K Buy
+1,379
New +$4.31K ﹤0.01% 1995

Other funds holding STIM

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Meeder Asset Management's STIM Position: Q2 2020 in Review

Meeder Asset Management sold out of Neuronetics (STIM) in Q2 2020, closing a stake of 1,379 shares — an estimated $3K sold.

Meeder Asset Management first reported a position in STIM in Q1 2020 and held it in 1 quarter. The position peaked at $3K in Q1 2020. 55 funds tracked by Wall St. Rank hold STIM as of Q2 2020.

  • Meeder Asset Management reported no remaining Neuronetics position as of Q2 2020 after selling out during the quarter.
  • Meeder Asset Management sold 1,379 Neuronetics shares in Q2 2020, an estimated $3K.
  • Meeder Asset Management first reported a position in Neuronetics in Q1 2020 and held it in 1 quarter.
  • Meeder Asset Management's Neuronetics position peaked at $3K in Q1 2020.
  • 55 funds tracked by Wall St. Rank held Neuronetics as of Q2 2020.

Based on Meeder Asset Management's 13F filing for Q2 2020, filed 11 Aug 2020.